An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis

NCT00207714 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

172

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Golimumab
DRUG: MTX
DRUG: Placebo
DRUG: Infliximab

Sponsor

Centocor, Inc.

Collaborators

[object Object]